CURE Pharmaceutical Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

  • CURE is granting equipment manufacturers , cannabis processing companies and cannabinoid drug developers licenses to its portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced SCFE technology utilizing carbon dioxide as the solvent.
  • The two patents cover the extraction and purification of cannabis plant material, as well as subsequent processing of cannabis extracts for drug formulation.
  • About CURE Pharmaceutical CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems.
  • CURE has an FDA- and DEA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform, a patented drug delivery platform.

Read full article: